RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Daiichi Sankyo Co Equity 2024

Daiichi Sankyo Co Equity

1.45 T JPY

Daiichi Sankyo Co Dividend yield

Ticker

4568.T

ISIN

JP3475350009

WKN

A0F57T

In 2024, Daiichi Sankyo Co's equity was 1.45 T JPY, a 7.03% increase from the 1.35 T JPY equity in the previous year.

Daiichi Sankyo Co Aktienanalyse

What does Daiichi Sankyo Co do?

Daiichi Sankyo Co Ltd is a company specialized in the production of medicines. The company was founded in 2005 and was formed from the merger of two Japanese pharmaceutical companies. However, the history of Daiichi Sankyo dates back to 1899 when the Daiichi Group and Sankyo Renkyu merged to form a cooperative. Both companies had been active in the pharmaceutical business since the 1960s and were specialized in the development and production of drugs. Daiichi Sankyo's business model is focused on developing and globally marketing innovative drugs. The company focuses on researching and marketing drugs for the treatment of cancer, cardiovascular diseases, and infectious diseases. Daiichi Sankyo is divided into different divisions. The pharmaceutical division is the company's most important business segment. Here, drugs for various applications are developed and produced, including medications for the therapy of cancer, cardiovascular diseases, and infections. Another division is the medical devices division. Here, medical devices such as catheters and stents for the treatment of cardiovascular diseases, as well as endoscopic devices for the diagnosis and therapy of gastrointestinal diseases, are manufactured. Another important area is the diagnostics division. Here, diagnostic test systems for various applications are developed and manufactured. Some of Daiichi Sankyo's best-known products include the cancer drug Trastuzumab Emtansin and the anticoagulant drug Prasugrel. Daiichi Sankyo is a globally operating company headquartered in Tokyo, Japan. In addition, the company has branches in North, Central, and South America, Europe, Asia, and Oceania. The company places great importance on research and development and participates in numerous collaborations and partnerships with universities and other companies. The goal is to constantly develop new groundbreaking drugs and contribute to the improvement of disease treatment. Overall, Daiichi Sankyo employs approximately 15,000 people worldwide and generates an annual revenue of around 8 billion euros. The company is thus one of the leading companies in the pharmaceutical and medical technology industry and will remain an important player in the global healthcare market in the future. Daiichi Sankyo Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Daiichi Sankyo Co's Equity

Daiichi Sankyo Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Daiichi Sankyo Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Daiichi Sankyo Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Daiichi Sankyo Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Daiichi Sankyo Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Daiichi Sankyo Co Stock

What is the equity of Daiichi Sankyo Co this year?

Daiichi Sankyo Co has equity of 1.45 T JPY this year.

What was the equity of Daiichi Sankyo Co compared to the previous year?

The equity of Daiichi Sankyo Co has increased/decreased by 7.03% increased compared to the previous year.

What impact does a high equity have on investors of Daiichi Sankyo Co?

A high equity is advantageous for investors of Daiichi Sankyo Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Daiichi Sankyo Co?

A low equity can be a risk for investors of Daiichi Sankyo Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Daiichi Sankyo Co affect the company?

An increase in equity of Daiichi Sankyo Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Daiichi Sankyo Co affect the company?

A reduction in equity of Daiichi Sankyo Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Daiichi Sankyo Co?

Some factors that can affect the equity of Daiichi Sankyo Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Daiichi Sankyo Co so important for investors?

The equity of Daiichi Sankyo Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Daiichi Sankyo Co take to change the equity?

To change equity, Daiichi Sankyo Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Daiichi Sankyo Co pay?

Over the past 12 months, Daiichi Sankyo Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Daiichi Sankyo Co is expected to pay a dividend of 35.49 JPY.

What is the dividend yield of Daiichi Sankyo Co?

The current dividend yield of Daiichi Sankyo Co is .

When does Daiichi Sankyo Co pay dividends?

Daiichi Sankyo Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Daiichi Sankyo Co?

Daiichi Sankyo Co paid dividends every year for the past 22 years.

What is the dividend of Daiichi Sankyo Co?

For the upcoming 12 months, dividends amounting to 35.49 JPY are expected. This corresponds to a dividend yield of 0.71 %.

In which sector is Daiichi Sankyo Co located?

Daiichi Sankyo Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Daiichi Sankyo Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Daiichi Sankyo Co from 6/1/2024 amounting to 30 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Daiichi Sankyo Co pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Daiichi Sankyo Co in the year 2023?

In the year 2023, Daiichi Sankyo Co distributed 28.5 JPY as dividends.

In which currency does Daiichi Sankyo Co pay out the dividend?

The dividends of Daiichi Sankyo Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Daiichi Sankyo Co stock can be added to a savings plan with the following providers: Consorsbank

Andere Kennzahlen von Daiichi Sankyo Co

Our stock analysis for Daiichi Sankyo Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Daiichi Sankyo Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.